An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Dr. Stephen Hauser, a Ross resident who is a neurology professor at the University of California at San Francisco, ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in the disease.

MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

In her candid revelation on the podcast 'MeSsy,' actress Christina Applegate opened up about her harrowing journey with multiple sclerosis (MS), shedding light on the reality of living with this ...